ArticleOncotarget2016
Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma.
Yordan Benhamou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it
ArticleOncotarget2016
Yordan Benhamou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.